Publications
Export 14 results:
Filtres: Author is Stip, Emmanuel [Enlever les filtres]
, « Antipsychotic utilization trajectories three years after initiating or reinitiating treatment of schizophrenia: A state sequence analysis approach », Acta Psychiatrica Scandinavica, vol. 145, nᵒ 5, p. 469 - 480, 2022.
, « Antipsychotic utilization trajectories three years after initiating or reinitiating treatment of schizophrenia: A state sequence analysis approach. », Acta Psychiatr Scand, vol. 145, nᵒ 5, p. 469-480, 2022.
, « Association between previous and future antipsychotic adherence in patients initiating clozapine: real-world observational study. », Br J Psychiatry, p. 1-8, 2022.
, « Comparative effectiveness and safety of antipsychotic drugs in patients with schizophrenia initiating or reinitiating treatment: A Real-World Observational Study. », Acta Psychiatr Scand, vol. 145, nᵒ 5, p. 456-468, 2022.
, « Multidimensional analysis of adult patients' care trajectories before a first diagnosis of schizophrenia. », Schizophrenia (Heidelb), vol. 8, nᵒ 1, p. 52, 2022.
, « [Psychopharmacology of First Episode Psychosis: An Approach Based on Recovery]. », Sante Ment Que, vol. 46, nᵒ 2, p. 113-137, 2021.
, « Urbanicity, Schizophrenia and Equitable Specialist Services Allocation. », Can J Psychiatry, p. 7067437211040606, 2021.
, « From QAAPAPLE 1 to QAAPAPLE 2: How do we move from one algorithm to another one with Long acting antipsychotics (LAIs). », Expert Rev Neurother, 2020.
, « [Long-acting antipsychotics: The QAAPAPLE algorithm review]. », Can J Psychiatry, p. 706743719847193, 2019.
, « An Exploratory, Open-Label, Randomized Trial Comparing Risperidone Long-Acting Injectable with Oral Antipsychotic Medication in the Treatment of Early Psychosis. », Clin Schizophr Relat Psychoses, vol. 9, nᵒ 4, p. 198-208, 2016.
, « [Long-acting injectable antipsychotics: an expert opinion from the Association des médecins psychiatres du Québec]. », Can J Psychiatry, vol. 56, nᵒ 6, p. 367-76, 2011.
, « Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia. », Am J Drug Alcohol Abuse, vol. 34, nᵒ 1, p. 75-82, 2008.
, « Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy. », J Psychopharmacol, vol. 22, nᵒ 3, p. 262-9, 2008.
, « Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial. », Curr Med Res Opin, vol. 22, nᵒ 7, p. 1277-85, 2006.
